# A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters

> **NCT00396253** · PHASE3 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 223 (actual)

## Conditions studied

- Dysfunctional Hemodialysis Catheters

## Interventions

- **DRUG:** Tenecteplase

## Key facts

- **NCT ID:** NCT00396253
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396253, "A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00396253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*